Stroke prevention – role of family doctor
Keywords:
stroke, risk factors, primary stroke prevention, secondary stroke preventionAbstract
Despite the huge progress achieved in medicine in recent years, stroke is still the third commonest cause of death and the leading cause of disability among people aged over 40 years. The incidence of stroke in Poland remains on an average European level, though the mortality rate is one of the highest in Europe. It seems that the main causes of this phenomenon is an insufficient primary and secondary prevention. Primary prevention aims at reducing the risk of occurring the first ischaemic stroke through so called modifiable risk factors whose occurrence can be changed by medical intervention or changes in patterns of behaviour. It affects not only decrease in stroke morbidity but also considerably influences the course of the disease. The main stroke risk factors are hypertension, atrial fibrillation, diabetes, nicotine addiction, high level of cholesterol and lack of physical activity. Secondary stroke prevention actually corresponds with primary stroke prevention and, additionally, should comprise antiplatelet or oral anticoagulant treatment, therapy of concomitant diseases and surgery of arterial thrombosis. The reduction and management of treatable risk factors as well as a modified way of life are among the most important goals of basic health care.
Downloads
References
Lloyd-Jones D, Adams R, Carnethon M, Brown TM, Carnethon M, Dai S i wsp. Heart Disease and Stroke Statistics—2010 Update. A Report From the American Heart Association. Circulation 2010;121;e46-e215;
Członkowska A, Ryglewicz D, Wiessbein T, Baranska-Gieruszczak M, Hier DB. A prospective community-based study of stroke in Warsaw, Poland. Stroke 1994; 25: 547-51.
Nowacki P, Porębska A, Bajer-Czajkowska A, Żywica A, Koziarska D, Podbielski J. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland. Ann Acad Med Stetin. 2007;53(2):14-9.
Nowacki P. Bajer-Czajkowska A. Profilaktyka wtórna niedokrwiennego udaru mózgu w świetle medycyny opartej na dowodach. Pol Przegl Neurol 2008; 4(3): 147-152.
Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD i wsp. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(6):1583-633.
Easton JD. Epidemiology of stroke recurrence. Cerebrovasc Dis 1997; Suppl.1, 2-4.
Wytyczne Grupy Ekspertów Narodowego Programu Profilaktyki i Leczenia Chorób Układu Sercowo-Naczyniowego POLKARD. Profilaktyka wtórna udaru mózgu. Neurol Neurochir Pol 2008; 42; 4(supl. 3): 247-260.
Romero JR. Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets. 2007 Jul;8(7):794-801.
Romero JR, Morris J, Pikula A. Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis. 2008;2(4):287-303.
Graham GD. Secondary stroke prevention: from guidelines to clinical practice. J Natl Med Assoc. 2008;100(10):1125-37.
Członkowska A. Pierwotna profilaktyka udaru mózgu. Przew Lek 2001; 4, 5: 15-21.
Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary Prevention of Stroke by Healthy Lifestyle. Circulation, 2008; 118: 947 - 954.
Bogousslavsky J, Kaste M, Olsen TS, Hacke W, Orgogozo J-M. Risk factors and stroke prevention. Cerebrovasc Dis 2000; 10, supl. 3, 12-21.
Garcia D, Hylek E. Stroke prevention in elderly patients with atrial fibrillation. Lancet. 2007 Aug 11;370(9586):460-1.
Staessen JA, Wang J. Blood-pressure lowering for secondary prevention of stroke. Lancet 2001; 358: 1026-7.
PROGRESS Collaborative Group, Randomised trial of perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
Feinberg W.M.: Primary and secondary stroke prevention. Curr. Opin. Neurol. 1996, 9: 46-52.
Blauw GJ, Lagaay M, Smelt AHM, Westendorp RJH. Stroke, statins and cholesterol: a meta analysis of randomised, placebo controlled, double blind trials with HMG-CoA reductase inhibitors. Stroke 1997; 28: 346-50.
Rosendorf C. Statins for prevention of stroke. Lancet 1998; 351: 1002.
Paciaroni M, Bogousslavsky J. Primary and secondary prevention of ischemic stroke. Eur Neurol. 2010;63(5):267-78.
Alamowitch S, Eliasziw M, Algra A. North American Symptomatic Carotid Endarterectomy Trial. Risk, causes and prevention of ischaemic stroke in eldery patients with symptomatic internal carotid artery stenosis. Lancet 2001; 357: 1154-60.
White CJ. Stroke prevention: carotid stenting versus carotid endarterectomy. F1000 Med Rep. 2010 Mar 25;2: 24.
Roffi M, Mukherjee D, Clair DG. Carotid artery stenting vs. endarterectomy. Eur Heart J. 2009;30(22):2693-704.
Kastrup A, Groschel K, Krapf H: Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003, 34: 813-819.
Toole J.F. i wsp.: Lowering homocysteine in patients with ischemic stroke prevent reccurent stroke, myocardial infarction, and death: the Vitamins Intervention for Stroke Prevention (VISP) randomised controlled trial. JAMA 2004, 291: 565-575.
Hankey G, Eikelboom J. Homocysteine and stroke. Lancet 2005; 365, 9455: 194-196
Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC i wsp. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke published online Oct 21, 2010;
Rincon F, Sacco RL. Secondary stroke prevention. J Cardiovasc Nurs. 2008 Jan-Feb; 23(1):34-41.
Diener H.: Leczenie przeciwzakrzepowe we wtórnej prewencji mózgu. Med Dypl 2003; 2: 131-142.
Członkowska A, Mirowska D. Chory po przebytym udarze mózgu - w gabinecie lekarza rodzinnego. Przew Lek 2001; 4, 11: 47-52.
Mołda-Wojciechowska E. Pacjent po udarze mózgu w gabinecie lekarza podstawowej opieki zdrowotnej – wtórna profilaktyka udaru. Pol Merk Lek 2008; 25, 145: 83-86.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
